- Release Date: 10/04/24 08:26
- Summary: Patient Dosing Milestone Achieved in Phase 2 Stroke Trial
- Price Sensitive: Yes
- Download Document 275.78KB
Ann: Patient Dosing Milestone Achieved in Phase 2 Stroke Trial
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.5¢ |
Change
-0.025(3.13%) |
Mkt cap ! $95.86M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 80.5¢ | 77.0¢ | $155.6K | 197.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9836 | 77.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.57pm 25/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |